Table 2.
Patient's characteristics according to the improvement or not in nocturia after HoLEP.
| Satisfactory improvement | Unsatisfactory improvement | P | |
|---|---|---|---|
| Patients | 80 | 95 | |
| Age, year | 66 (60/71) | 73 (67/79) | <0.001 |
| BMI, kg/m2 | 24.3 (22.3/26.2) | 24.2 (22.3/26.6) | 0.690 |
| Hypertension | 33/80 (41%) | 47/95 (49%) | 0.277 |
| SBP, mmHg | 132 (125/137) | 132 (126/140) | 0.406 |
| DBP, mmHg | 76 (74/82) | 76 (74/80) | 0.930 |
| Diabetes mellitus | 12/80 (15%) | 26/95 (27%) | 0.048 |
| Smoking | 37/80 (46%) | 40/95 (42%) | 0.582 |
| Alcohol | 38/80 (48%) | 34/95 (36%) | 0.117 |
| WC, cm | 91 (87/96) | 93 (87/97) | 0.239 |
| TG, mmol/L | 1.00 (0.74/1.44) | 1.09 (0.72/1.47) | 0.654 |
| HDL, mmol/L | 1.21 (0.96/1.39) | 1.17 (0.94/1.39) | 0.509 |
| Fasting glucose, mmol/L | 4.76 (4.48/5.20) | 5.06 (4.61/5.96) | 0.001 |
| Operation time, min | 78 (60/100) | 80 (60/100) | 0.294 |
| Hb change, g/L | 9 (4/13) | 7 (4/14) | 0.724 |
| MetS | 19/80 (24%) | 44/95 (46%) | 0.002 |
| No. MetS component | 2 (1/2) | 2 (1/3) | 0.011 |
| Prostate volume, cc | 58 (43/82) | 66 (47/89) | 0.233 |
| Total PSA, ng/ml | 3.42 (1.57/8.72) | 3.37 (1.40/6.90) | 0.644 |
| Preoperative IPSS | |||
| Total | 21 (17/27) | 20 (16/27) | 0.509 |
| vIPSS | 13 (10/16) | 12 (10/15) | 0.400 |
| sIPSS | 9 (7/12) | 10 (6/12) | 0.838 |
| IPSS 3 mo | |||
| Total | 3 (2/5) | 6 (4/9) | <0.001 |
| vIPSS | 1 (0/2) | 1 (0/3) | 0.017 |
| sIPSS | 2 (1/4) | 4 (3/6) | <0.001 |
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; WC, waist circumference; TG, triglycerides; HDL, high-density lipoprotein; MetS, metabolic syndrome; PSA, prostatespecific antigen; IPSS, International Prostate Symptom Score; vIPSS, voiding International Prostate Symptom Score; sIPSS, storage International Prostate Symptom Score.